Abstract
Background: Chronic Obstructive Pulmonary Disease (COPD) and Ischemic Heart Disease (IHD) are cost-intense and highly prevalent diseases in Germany. Owing to shared risk factors, the co-occurrence of both diseases is very likely, with consequences on morbidity, mortality, and costs of care. Our claims data-based study aimed at quantifying IHD-associated excess costs in individuals with COPD from the perspective of the German Statutory Health Insurance (SHI).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
